Abstract
Leptin is an adipocyte-secreted hormone, the circulating levels of which correlate closely with overall adiposity. Although rare mutations in the leptin (LEP) gene are well known to cause leptin deficiency and severe obesity, no common loci regulating circulating leptin levels have been uncovered. Therefore, we performed a genome-wide association study (GWAS) of circulating leptin levels from 32,161 individuals and followed up loci reaching P<10-6 in 19,979 additional individuals. We identify five loci robustly associated (P<5 × 10-8) with leptin levels in/near LEP, SLC32A1, GCKR, CCNL1 and FTO. Although the association of the FTO obesity locus with leptin levels is abolished by adjustment for BMI, associations of the four other loci are independent of adiposity. The GCKR locus was found associated with multiple metabolic traits in previous GWAS and the CCNL1 locus with birth weight. Knockdown experiments in mouse adipose tissue explants show convincing evidence for adipogenin, a regulator of adipocyte differentiation, as the novel causal gene in the SLC32A1 locus influencing leptin levels. Our findings provide novel insights into the regulation of leptin production by adipose tissue and open new avenues for examining the influence of variation in leptin levels on adiposity and metabolic health.
Original language | English |
---|---|
Article number | 10494 |
Journal | Nature communications |
Volume | 7 |
DOIs | |
State | Published - Feb 1 2016 |
Fingerprint
Dive into the research topics of 'Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Nature communications, Vol. 7, 10494, 01.02.2016.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels
AU - Kilpeläinen, Tuomas O.
AU - Carli, Jayne F.Martin
AU - Skowronski, Alicja A.
AU - Sun, Qi
AU - Kriebel, Jennifer
AU - Feitosa, Mary F.
AU - Hedman, Åsa K.
AU - Drong, Alexander W.
AU - Hayes, James E.
AU - Zhao, Jinghua
AU - Pers, Tune H.
AU - Schick, Ursula
AU - Grarup, Niels
AU - Kutalik, Zoltán
AU - Trompet, Stella
AU - Mangino, Massimo
AU - Kristiansson, Kati
AU - Beekman, Marian
AU - Lyytikäinen, Leo Pekka
AU - Eriksson, Joel
AU - Henneman, Peter
AU - Lahti, Jari
AU - Tanaka, Toshiko
AU - Luan, Jian'an
AU - Fabiola Del, Greco M.
AU - Pasko, Dorota
AU - Renström, Frida
AU - Willems, Sara M.
AU - Mahajan, Anubha
AU - Rose, Lynda M.
AU - Guo, Xiuqing
AU - Liu, Yongmei
AU - Kleber, Marcus E.
AU - Pérusse, Louis
AU - Gaunt, Tom
AU - Ahluwalia, Tarunveer S.
AU - Ju Sung, Yun
AU - Ramos, Yolande F.
AU - Amin, Najaf
AU - Amuzu, Antoinette
AU - Barroso, Inês
AU - Bellis, Claire
AU - Blangero, John
AU - Buckley, Brendan M.
AU - Böhringer, Stefan
AU - I Chen, Yii Der
AU - De Craen, Anton J.N.
AU - Crosslin, David R.
AU - Dale, Caroline E.
AU - Dastani, Zari
AU - Day, Felix R.
AU - Deelen, Joris
AU - Delgado, Graciela E.
AU - Demirkan, Ayse
AU - Finucane, Francis M.
AU - Ford, Ian
AU - Garcia, Melissa E.
AU - Gieger, Christian
AU - Gustafsson, Stefan
AU - Hallmans, Göran
AU - Hankinson, Susan E.
AU - Havulinna, Aki S.
AU - Herder, Christian
AU - Hernandez, Dena
AU - Hicks, Andrew A.
AU - Hunter, David J.
AU - Illig, Thomas
AU - Ingelsson, Erik
AU - Ioan-Facsinay, Andreea
AU - Jansson, John Olov
AU - Jenny, Nancy S.
AU - Jørgensen, Marit E.
AU - Jørgensen, Torben
AU - Karlsson, Magnus
AU - Koenig, Wolfgang
AU - Kraft, Peter
AU - Kwekkeboom, Joanneke
AU - Laatikainen, Tiina
AU - Ladwig, Karl Heinz
AU - Leduc, Charles A.
AU - Lowe, Gordon
AU - Lu, Yingchang
AU - Marques-Vidal, Pedro
AU - Meisinger, Christa
AU - Menni, Cristina
AU - Morris, Andrew P.
AU - Myers, Richard H.
AU - Männistö, Satu
AU - Nalls, Mike A.
AU - Paternoster, Lavinia
AU - Peters, Annette
AU - Pradhan, Aruna D.
AU - Rankinen, Tuomo
AU - Rasmussen-Torvik, Laura J.
AU - Rathmann, Wolfgang
AU - Rice, Treva K.
AU - Brent Richards, J.
AU - Ridker, Paul M.
AU - Sattar, Naveed
AU - Savage, David B.
AU - Söderberg, Stefan
AU - Timpson, Nicholas J.
AU - Vandenput, Liesbeth
AU - Van Heemst, Diana
AU - Uh, Hae Won
AU - Vohl, Marie Claude
AU - Walker, Mark
AU - Wichmann, Heinz Erich
AU - Widén, Elisabeth
AU - Wood, Andrew R.
AU - Yao, Jie
AU - Zeller, Tanja
AU - Zhang, Yiying
AU - Meulenbelt, Ingrid
AU - Kloppenburg, Margreet
AU - Astrup, Arne
AU - Sørensen, Thorkild I.A.
AU - Sarzynski, Mark A.
AU - Rao, D. C.
AU - Jousilahti, Pekka
AU - Vartiainen, Erkki
AU - Hofman, Albert
AU - Rivadeneira, Fernando
AU - Uitterlinden, André G.
AU - Kajantie, Eero
AU - Osmond, Clive
AU - Palotie, Aarno
AU - Eriksson, Johan G.
AU - Heliövaara, Markku
AU - Knekt, Paul B.
AU - Koskinen, Seppo
AU - Jula, Antti
AU - Perola, Markus
AU - Huupponen, Risto K.
AU - Viikari, Jorma S.
AU - Kähönen, Mika
AU - Lehtimäki, Terho
AU - Raitakari, Olli T.
AU - Mellström, Dan
AU - Lorentzon, Mattias
AU - Casas, Juan P.
AU - Bandinelli, Stefanie
AU - März, Winfried
AU - Isaacs, Aaron
AU - Van Dijk, Ko W.
AU - Van Duijn, Cornelia M.
AU - Harris, Tamara B.
AU - Bouchard, Claude
AU - Allison, Matthew A.
AU - Chasman, Daniel I.
AU - Ohlsson, Claes
AU - Lind, Lars
AU - Scott, Robert A.
AU - Langenberg, Claudia
AU - Wareham, Nicholas J.
AU - Ferrucci, Luigi
AU - Frayling, Timothy M.
AU - Pramstaller, Peter P.
AU - Borecki, Ingrid B.
AU - Waterworth, Dawn M.
AU - Bergmann, Sven
AU - Waeber, Gérard
AU - Vollenweider, Peter
AU - Vestergaard, Henrik
AU - Hansen, Torben
AU - Pedersen, Oluf
AU - Hu, Frank B.
AU - Eline Slagboom, P.
AU - Grallert, Harald
AU - Spector, Tim D.
AU - Jukema, J. W.
AU - Klein, Robert J.
AU - Schadt, Erik E.
AU - Franks, Paul W.
AU - Lindgren, Cecilia M.
AU - Leibel, Rudolph L.
AU - Loos, Ruth J.F.
N1 - Funding Information: The full list of acknowledgements appears in the Supplementary Information. Funding for this study was provided by the Academy of Finland (41071, 117787, 118065, 121584, 124282, 126925, 129494, 129322, 129378, 130326, 134309, 134791, 136895, 139635, 250207, 263836, 286284 and 263924); Ahokas Foundation; ALF/LUA research grant in Gothenburg; Amgen; Augustinus Foundation; Becket Foundation; Bristol-Myers Squibb; British Heart Foundation programme (PG/13/66/30442 and PG/07/131/24254); Canadian Institutes of Health Research (FRCN-CCT-83028); Centre for Medical Systems Biology; Danish Centre for Health Technology Assessment; Danish Council for Independent Research (DFF-1333-00124 and DFF-1331-00730B); Danish Diabetes Association; Danish Heart Foundation; Danish Pharmaceutical Association; Danish Research Council; Department of Health Policy Research Programme (0090049); Diabetes UK; Donald W. Reynolds Foundation; Dutch Arthritis Association (DAA 2010_017); Dutch government (NWO 184.021.007); Emil Aaltonen Foundation; Erasmus MC; Erasmus University; European Commission (FP6-LSHG-CT-2006-018947, FP6-LSHG-CT-2006-01947, HEALTH-F2-2008-201865-GEFOS, FP7-201668, FP7-223004, FP7-259679, FP7-305739 and FP7-IDEAS-ERC-323195); European Regional Development Fund; EUROSPAN; Faculty of Biology and Medicine of Lausanne; Finnish Centre for Pensions; Finnish Cultural Foundation; Finnish Diabetes Research Society; Finnish Foundation of Cardiovascular Research; Finnish Foundation for Pediatric Research; Finnish National Institute for Health and Welfare; Finnish Special Governmental Subsidy for Health Sciences; Finska Läkaresällskapet; Folkhälsan Research Foundation; Genetic Laboratory of the Department of Internal Medicine, Erasmus MC; German Center for Diabetes Research (DZD); German Federal Ministry of Education and Research; GlaxoSmithKline; Göran Gustafsson Foundation; Heart Foundation of Northern Sweden; Helmholtz Zentrum München; Ib Henriksen Foundation; Innovation- Oriented Research Program on Genomics (SenterNovem IGE05007); Italian Ministry of Health (ICS110.1/RF97.71); John W. Barton Sr. Chair in Genetics and Nutrition; Juho Vainio Foundation; King’s College London; Knut and Alice Wallenberg Foundation; Kuopio, Tampere and Turku University Hospital Medical Funds (X51001, 9M048, 9N035); Leiden University Medical Centre; Li Ka Shing Foundation; Liv och Hälsa; Local Government Pensions Institution; Ludwig-Maximilians-Universität; Lundbeck Foundation; Lundberg Foundation; Medical Research Council (MC_U106179471, MC_UU_12013/3, and MC_UU_12013/8); Medical Research Council-GlaxoSmithKline pilot programme grant (G0701863); Ministry of Education, Culture and Science of the Netherlands; Ministry of health, Welfare and Sports of the Netherlands; Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano; Danish Ministry of Internal Affairs and Health; Munich Center of Health Sciences; Municipality of Rotterdam; National Cancer Institute (CA047988); National Eye Institute; National Institute on Aging (Intramural research programme, N01AG62101, N01AG62103, N01AG62106, 1R01AG032098-01A1, 263MD9164 and 263 MD 821336); National Institute for Health Research; National Institutes of Health (DK52431, HG004399, HG004446, CA087969, CA055075, DK058845, CA65725, CA49449, CA67262, CA50385 and UO1CA098233); Netherlands Brain Foundation (HersenStichting Nederland); Netherlands Consortium for Healthy Aging (050-060-810); Netherlands Genomics Initiative; Netherlands Heart Foundation (2001 D 032); Netherlands Organization for Scientific Research (175-010-2005-011, 904- 61-095, 911-03-012, 911-03-016, 917-66-344 and 911-03-012); Netherlands Organization for the Health Research and Development; National Heart, Lung, and Blood Institute (5R01HL068891, 5R01HL087700, R01HL117078, HHSN26800625226C, HHSN268200782096C, HL-043851, HL-045670, HL080467, N01-HC95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, N02-HL-64278, N01-HC-65226, R01-HL-071051, R01-HL-071205, R01-HL-071250, R01-HL-071251, R01-HL-071252, R01-HL-071258, R01-HL-071259, R01-HL-088451, R00-HL-098459, U01-HG007033, UL1-RR-24156, UL1-RR-25005, UL1-TR-000040 and UL1-TR-001079); National Health Service Foundation Trust; National Institutes of Diabetes and Digestive and Kidney Diseases (1R01DK080015, R01DK089256, 5R01DK068336, 5R01DK075681 and 5R01DK07568102); Novo Nordisk; Novo Nordisk Foundation; New York Obesity Nutrition Research Center Pilot and Feasilibity Grant (DK-26687); Orion-Farmos Research Foundation; Pfizer Inc.; Paavo Nurmi Foundation; Påhlssons Foundation; Research Foundation of Copenhagen County; Roche Pharmaceuticals; Research Institute for Diseases in the Elderly (014-93-015; RIDE2); Samfundet Folkhälsan; Signe and Ane Gyllenberg Foundation; Sigrid Juse´lius Foundation; Social Insurance Institution of Finland; South Tyrolean Sparkasse Foundation; Swedish Diabetes Association; Swedish Diabetes Foundation; Swedish Foundation for Strategic Research; Swedish Heart-Lung Foundation (20140422); Swedish Research Council (2012-1397); Swiss Institute of Bioinformatics; Swiss National Science Foundation (3100AO-116323/1, 33CSCO-122661, 33CS30-139468 and 33CS30-148401); Tampere Tuberculosis Foundation; Torsten and Ragnar So¨derberg’s Foundation; Umeå University Career Development Award; Unilever Colworth; Wellcome Trust (WT064890, WT089062, WT090532, WT098017, WT098051, WT091551, 081917/Z/07/Z and 086596/Z/08/Z); Wellcome Trust Centre for Human Genetics core funding (090532); Wissenschaftsoffensive TMO; Yrjo¨ Jahnsson Foundation.
PY - 2016/2/1
Y1 - 2016/2/1
N2 - Leptin is an adipocyte-secreted hormone, the circulating levels of which correlate closely with overall adiposity. Although rare mutations in the leptin (LEP) gene are well known to cause leptin deficiency and severe obesity, no common loci regulating circulating leptin levels have been uncovered. Therefore, we performed a genome-wide association study (GWAS) of circulating leptin levels from 32,161 individuals and followed up loci reaching P<10-6 in 19,979 additional individuals. We identify five loci robustly associated (P<5 × 10-8) with leptin levels in/near LEP, SLC32A1, GCKR, CCNL1 and FTO. Although the association of the FTO obesity locus with leptin levels is abolished by adjustment for BMI, associations of the four other loci are independent of adiposity. The GCKR locus was found associated with multiple metabolic traits in previous GWAS and the CCNL1 locus with birth weight. Knockdown experiments in mouse adipose tissue explants show convincing evidence for adipogenin, a regulator of adipocyte differentiation, as the novel causal gene in the SLC32A1 locus influencing leptin levels. Our findings provide novel insights into the regulation of leptin production by adipose tissue and open new avenues for examining the influence of variation in leptin levels on adiposity and metabolic health.
AB - Leptin is an adipocyte-secreted hormone, the circulating levels of which correlate closely with overall adiposity. Although rare mutations in the leptin (LEP) gene are well known to cause leptin deficiency and severe obesity, no common loci regulating circulating leptin levels have been uncovered. Therefore, we performed a genome-wide association study (GWAS) of circulating leptin levels from 32,161 individuals and followed up loci reaching P<10-6 in 19,979 additional individuals. We identify five loci robustly associated (P<5 × 10-8) with leptin levels in/near LEP, SLC32A1, GCKR, CCNL1 and FTO. Although the association of the FTO obesity locus with leptin levels is abolished by adjustment for BMI, associations of the four other loci are independent of adiposity. The GCKR locus was found associated with multiple metabolic traits in previous GWAS and the CCNL1 locus with birth weight. Knockdown experiments in mouse adipose tissue explants show convincing evidence for adipogenin, a regulator of adipocyte differentiation, as the novel causal gene in the SLC32A1 locus influencing leptin levels. Our findings provide novel insights into the regulation of leptin production by adipose tissue and open new avenues for examining the influence of variation in leptin levels on adiposity and metabolic health.
UR - http://www.scopus.com/inward/record.url?scp=84970934641&partnerID=8YFLogxK
U2 - 10.1038/ncomms10494
DO - 10.1038/ncomms10494
M3 - Article
C2 - 26833098
AN - SCOPUS:84970934641
SN - 2041-1723
VL - 7
JO - Nature communications
JF - Nature communications
M1 - 10494
ER -